Back Cover: Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens

Ternette Nicola; Olde Nordkamp Marloes J. M.; Müller Julius; Anderson Amanda P.; Nicastri Annalisa; Hill Adrian V. S.; Kessler Benedikt M.; Li Demin

首页> 外文期刊>Proteomics >Back Cover: Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens

【24h】

Back Cover: Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens

机译：返回盖子：HLA-A2阳性三重阴性乳腺癌的免疫肽谱析出鉴定潜在的免疫治疗靶抗原

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Proteomics》 |2018年第12期|共1页
作者
Ternette Nicola; Olde Nordkamp Marloes J. M.; Müller Julius; Anderson Amanda P.; Nicastri Annalisa; Hill Adrian V. S.; Kessler Benedikt M.; Li Demin;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类生物化学;
关键词

相似文献

外文文献
中文文献
专利

1. Back Cover: Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens [J] . Ternette Nicola, Olde Nordkamp Marloes J. M., Müller Julius, Proteomics . 2018,第12期

机译：返回盖子：HLA-A2阳性三重阴性乳腺癌的免疫肽谱析出鉴定潜在的免疫治疗靶抗原
2. Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer [J] . CabezónT., GromovaI., GromovP., Molecular & cellular proteomics: MCP . 2013,第2期

机译：三阴性乳腺癌的蛋白质组学分析与三层正交技术方法相结合，确定了Mage-A4是雌激素受体阴性乳腺癌的潜在治疗靶标
3. Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets [J] . Wang Xiaosheng, Guda Chittibabu Medicine. . 2016,第30期

机译：对三阴性乳腺癌基因组谱的综合探索确定了潜在的药物靶标
4. Anti-Annexin A2 conjugated shAnnexin A2 loaded PLGA nanoparticles for targeted delivery of siRNA for breast cancer therapy [C] . A. Mukerjee, A. P. Ranjan, J. K. Vishwanatha Annual meeting exposition of the Controlled Release Society . 2010

机译：抗Annexin A2缀合的shAnnexin A2负载的PLGA纳米颗粒用于靶向siRNA的乳腺癌治疗
5. Preclinical exploration of novel small molecules as anticancer agents in triple-negative and HER2/neu-positive breast cancers. [D] . Weng, Shu-Chuan. 2008

机译：在三阴性和HER2 / neu阳性乳腺癌中作为抗癌药的新型小分子的临床前探索。
6. Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens [O] . Nicola Ternette, Marloes J. M. Olde Nordkamp, Julius Müller, -1

机译：HLA-A2阳性三阴性乳腺癌的免疫肽谱分析可确定潜在的免疫治疗靶标抗原
7. Back Cover: Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens [O] . Nicola Ternette, Marloes J. M. Olde Nordkamp, Julius Müller, 2018

机译：封面：HLA-A2阳性三重阴性乳腺癌的免疫肽谱析出鉴定潜在的免疫疗法靶抗原

Back Cover: Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens

著录项

相似文献

相关主题

期刊订阅